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Abstract
Background: The systemic antimicrobial prophylaxis is the standard treatment in the prevention of osteomyelitis after open frac-
tures, with topical application of antimicrobials as an alternative due to their high concentrations at the site of the fracture, low
systemic concentrations and fewer side effects.
Objectives: This study aimed to evaluate the effectiveness of prophylaxis of osteomyelitis through experimental model of open
fractures with the use of chitosan films, whether or not impregnated with ciprofloxacin.
Materials andMethods: In this experimental study, 24 Holtzman rats were distributed into 4 groups of 6 rats each. The CT (control
of treatment) group: an open fracture model treated with systemic antimicrobial; the IC (infection control) group: an open fracture
untreated model; the C (chitosan) group: an open fracture model treated using a chitosan film; and the CA (chitosan with antimi-
crobial) group: an open fracture model treated using a chitosan film impregnated with antimicrobial. After 3 weeks the animals
were killed by an overdose of anesthetic, and a fragment osseous was removed for histological and microbiological analysis. The
comparisons between the groups considered significant values of P≤ 0.05.
Results: In cultures of the CT group, there was less bacterial growth compared to the results of the cultures of the IC (P = 0.005), C
(P = 0.005) and CA (P = 0.009) groups. The inflammation was lower in the CT group compared to the IC (P = 0.014), C (P = 0.001) and
CA (P = 0.007) groups.
Conclusions: In this experimental model of open fracture, the chitosan film pure or impregnated with ciprofloxacin was not effec-
tive in the prophylaxis of osteomyelitis.
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1. Background
The incidence of open fractures in long bones is esti-
mated 11.5 in 100.000 people (1); the purpose of the treat-
ment is to prevent infection, promote fracture healing and
restore function (2). Despite treatment, about 10% to 50%
will progress to osteomyelitis (3-5). Systemic prophylaxis is
the standard for the treatment of open fractures since 1974,
and its benefit was confirmed by a Cochrane review, where
it was observed that the use of antibiotics after open frac-
tures reduces the risk of infection by 59% (6).
Over the last decade, it has increased trend for the
application of topical antimicrobial prophylaxis of os-
teomyelitis secondary to open fractures (7). This method
provides high concentration of an antimicrobial at the site
of the fracture with low systemic concentration, reducing
the risk of side effects (7). The most frequently used for
this purpose, is the polymethylmethacrylate (PMMA). An
alternative is chitosan, a biological product derived from
the chitin of shellfish, bioabsorbable (8), bactericidal (9)
and allowing storage and gradual release of drugs (10), in-
cluding antimicrobials. Dehydrated chitosan films have
the ability to rapidly rehydrate and absorb drugs (11). Ma-
nipulation of the properties of this film during production
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may improve the local distribution of assisting in the pro-
phylaxis of antimicrobial infections (10, 11).
2. Objectives
The aim of this study was to evaluate the effective-
ness of prophylaxis of osteomyelitis secondary to open
fractures in an experimental model with chitosan films,
whether or not impregnated with ciprofloxacin compar-
ing with standard treatment with antibiotic prophylaxis.
3. Materials andMethods
Between January and August 2015, 24 males Holtz-
man rats selected from Universidade federal de minas
Gerais (UFMG), with approximately three months of life
and weighing 261.95± 20.82 were divided into 4 groups:
The control treatment (CT) group (n = 6): open fracture
treated with systemic antimicrobial.
The infection control (IC) group (n = 6): open fracture
without treatment.
The chitosan (C) group (n = 6): open fracture treated
with a pure chitosan film.
The chitosan with antimicrobial (CA) group (n = 6):
open fracture treated with a chitosan film impregnated
with ciprofloxacin.
The rats were placed in cages with three animals of the
same group at the vivarium of the UFMG Medical School
with water and rat food, temperature control, ventilation
and natural day-night cycle under daily monitoring by the
researchers. The animals were anesthetized and main-
tained under sedation by intraperitoneal injection of ke-
tamine and xylazine at doses of 15 mg/kg and 60 mg/kg,
respectively. The femoral fracture of the left hind leg of
the animal was performed using special equipment that
makes the fracture with a similar pattern in all the animals
(Figure 1). After the trichotomy on the left hand, antisepsis
was done with polivinilpirrolidona (Povidine® - Johnson
& Johnson, Brazil) in degerming solution, followed by an
alcoholic solution. The protection of the area with sterile
drapes was done, keeping exposed the paw to be operated.
After sterile surgical scrub was done, an incision was made
longitudinal in the middle third of the left thigh and dis-
section by planes to exposure the femoral fracture. The in-
tramedullary fixation of the fracture was performed using
a needle aspiration 40× 1.2 mm and 0.1 milliliters of inoc-
ulated suspension of Staphylococcus aureus (UFMG Central
Lab) in concentration of 10 CFU/mL set by McFarland (12),
applied in the bed of the fracture. The wound was sutured
with nonabsorbable monofilament nylon 5-0 (Mononylon
Ethicon®).
Figure 1. Special Equipment That Was Used to Make the Fracture
In the C, and CA groups, the sterile chitosan film was
placed in the bed of the fracture with dimensions of 0.5
cm×0.5 cm pure and impregnated with ciprofloxacin 10%
(Shaanxi New LeaderTraiding Co. Ltd. China.) respectively,
followed by the closure of the wound in previous groups.
After surgery the animals were kept in the vivarium, with
water and food. Analgesia was performed through solu-
tion of meloxicam (Mobic® - Boehringer Ingelheim Brazil
Ltda, SP, Brazil) with a dose of 0.2 mg/kg subcutaneously on
the immediate postoperative period.
The CT group was treated with ciprofloxacin (Ciprodez
® - Bio -Vet S/A, SP, Brazil) intraperitoneal dose of 2.5
mg/kg/day, for three days and the IC group did not re-
ceive any treatment to open fracture. The wound was daily
evaluated and the sutures were removed 10 days after the
surgery. After three weeks, the animals were killed through
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anesthetic overdose under aseptic conditions, the femur
was removed and the material submitted to qualitative
culture and histological analysis.
The cultures were performed on blood agar and con-
sidered positive when showed bacterial growth in 72 hours
with the same microorganism inoculated in the medullary
bed (Staphylococcus aureus). In all groups qualitative cul-
tures were performed in the suspension with S. aureus to
ensure the presence of bacteria in the fracture of the femur
of the studied animals. All S. aureus isolated were submit-
ted to antibiogram to verify sensitivity to ciprofloxacin.
For histological examination, the samples were
stained with hematoxylin-eosin and evaluated by the
same pathologist in conventional optical microscopy
researching osteomyelitis in activity. Histological classi-
fication was performed based on data for intraosseous
acute inflammation, intraosseous chronic inflammation,
periosteal inflammation and bone necrosis using the sys-
tem of Smeltzer et al. (13). Each parameter was graded on
a five-point scale (zero to four) and the sum of respective
histological parameters calculated as a total histological
score.
The study was approved by the ethics committee of an-
imal use at Universidade federal de Minas Gerais (UFMG),
under protocol 240/2011.
3.1. Data Analysis
The sample size was calculated using Minitab® version
14.1 software (Minitab Inc., PA, USA), and alpha = 0.05, test
power > 0.80 and maximum deviation between the results
equal to the average, resulting in six sample animals per
group. The values of mean and standard deviation were es-
tablished after performing a pilot project.
The data were analyzed by the software EPI inform
7.1.2.0 for Windows® (Atlanta, USA) using Fisher’s exact
test to compare the qualitative variables and the Mann-
Whitney test to compare quantitative variables. Weight dif-
ference between groups was detected by the Kruskal-Wallis
test. Differences were considered significant with P < 0.05.
4. Results
There was no significant difference in the average
weight of the animals between the groups (Table 1). A sig-
nificant difference was observed between the cultures of
the CT group compared with the cultures of the IC, C and
CA groups (Table 2). The antibiogram showed sensitivity of
the isolated bacteria to ciprofloxacin. Histological analysis
showed a significant difference in the total points of ani-
mals undergoing treatment with systemic antibiotic pro-
phylaxis (the CT group) compared to the other groups. It
was also seen that when parameters of this scoring system
were evaluated in isolation, the biggest difference between
the animals of the group treated with antibiotic prophy-
laxis (the CT group) and the others was the degree of in-
traosseous chronic inflammation. The comparison of his-
tological results is summarized in Table 3.
Table 1. Animals Weight in the Different Groups
Group AnimalsWeight
Mean (g) SD (g) P Value
CT 252,50 20,29 -
IC 265,83 16,55 0,44
C 259,50 20,40 0,84
CA 270,00 26,13 0,56
Abbreviations: SD, standard deviation; g, gram.
Table 2. Results of Qualitative Cultures in the Different Groups
Group Culture Results P Value
Positive Negative
CT 0 6 -
IC 5 1 0.005
C 6 0 0.009
CA 5 1 0.005
5. Discussion
The most important finding of this study was that a chi-
tosan film impregnated with ciprofloxacin can be used for
local delivery of antibiotics in open fractures wound; how-
ever, the concentrations of 10% of ciprofloxacin is not effec-
tive to prevent the development of infection in a rat model
of open fracture.
The principles in the treatment of open fractures are
the surgical emergency treatment, appropriate antibiotic
therapy, adequate irrigation and debridement, stabiliza-
tion of the fracture, wound healing and rehabilitation. In-
fection is the most common complication of open frac-
tures and antibiotic therapy should be performed in all
cases of open fractures (4, 5). The use of systemic antimi-
crobials has been considered the standard in the treat-
ment of open fractures since 1974 when Patzakis et al. (14)
observed that patients treated with cephalothin showed
lower rates of osteomyelitis compared to patients treated
with penicillin and streptomycin. The ideal time for treat-
ment with antimicrobials is uncertain and most authors
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Table 3. Degree of Inflammation of Bone Fragment Through the Score Smeltzer
Value BoneHistology P Value
Mean Punctuation
CT Group
Intraosseous acute inflammation 0± 0 -
Intraosseous chronic inflammation 1.0± 0.6 -
Periosteal inflammation 1.5± 1.6 -
Bone necrosis 1.7± 0.4 -
Total 2.7± 1.9 -
IC Group
Intraosseous acute inflammation 0.3± 0.8 0,34
Intraosseous chronic inflammation 3.7± 0.5 0.001
Periosteal inflammation 0± 0 0.049
Bone necrosis 1.8± 1.2 0,74
Total 5.8± 1.7 0.014
C Group
Intraosseous acute inflammation 2.0± 1.9 0.027
Intraosseous chronic inflammation 3.7± 0.5 0.001
Periosteal inflammation 2.0± 1.1 0.54
Bone necrosis 2.8± 1.5 0,09
Total 10.5± 3.1 0.001
CA Group
Intraosseous acute inflammation 1.5± 1.2 0,13
Intraosseous chronic inflammation 3.5± 0.5 0.000025
Periosteal inflammation 0.8± 0.4 0,35
Bone necrosis 0.8± 0.4 0.005
Total 6.7± 2.2 0.007
recommend its use for up to three days after injury (15).
Despite the intravenous use is still considered the stan-
dard, the local application of antibiotics seems as an alter-
native for prophylaxis of bone infections leading to high
local concentrations of antibiotics and low systemic levels
(16). The choice of the antimicrobial agent to be used is
also controversial, with ciprofloxacin been an option in the
treatment of open fractures due to its action against Gram-
positive and Gram-negative organisms (17).
In the present study, an experimental model of an open
fracture was performed to evaluate the effectiveness of
prophylaxis of infection in each group tested, verifying the
occurrence of osteomyelitis. This model was suggested by
Lindsey et al. (12), who proved an index of reproducible
osteomyelitis of 90% to 100% after 21 days after the exper-
imental fracture, the same was observed in this research,
because five of the six animals in the IC group developed in-
fection after a period of 21 days after surgery. Ciprofloxacin
was used for acting appropriately in the prophylaxis of in-
fections secondary to open fractures and was stable when
combined with a chitosan film. The antibiotic was used for
three days after the injury.
PMMA is the current standard vehicle for local antibi-
otics delivery in orthopedic surgery (18-21). However, it
needs thermostable antibiotics, provides uncontrolled re-
lease of drugs and surgical removal is necessary because it
is not biodegradable (21). A number of experimental stud-
ies have suggested the use of other options for local antibi-
otic delivery such as a chitosan film impregnated with an-
timicrobial (16, 21-25).
In this study, chitosan was used as a vehicle, because it
has the ability to transport drugs like PMMA, with the addi-
tional benefit of possessing antibacterial activity (26) and
be biodegradable (8, 16, 21, 25); so, a second surgical pro-
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cedure is not required to remove it from the wound. Be-
sides, chitosan does not increase the temperature during
the manufacturing process and can be combined with any
antibiotic, not requiring drugs that have thermal stability.
Although Aimin et al. (27) describe the reduction of the
infection rate of S. aureus osteomyelitis in an experimental
model using pure chitosan; we did not get the same result.
The animals of the C group received pure chitosan films as
a treatment for the model of open fracture and presented
a high rate of osteomyelitis compared to the CT group that
received antibiotic prophylaxis, with a significant differ-
ence. Histological evaluation also showed a higher degree
of intraosseous chronic inflammation in the C group com-
pared to the CT group, with a significant difference. This
result may have been due to the small size of a chitosan
film used in our research or extensive soft tissue injury
caused by the equipment for inducing fracture that results
in more favorable environment to infection.
Orhan et al. (22) evaluated the efficacy of chitosan mi-
crospheres and pectin impregnated with ciprofloxacin in
a model of local treatment of osteomyelitis and concluded
that this type of treatment was higher than the equiva-
lent treatment intramuscular antimicrobial. Stinner et al.
(16) evaluated the efficacy of a chitosan sponge impreg-
nated with amikacin or vancomycin in a model of com-
plex musculoskeletal wound and concluded that this treat-
ment was effective in reducing the bacteria concentration
within the wound. In this study, different results were ob-
tained. The CA group exposed to the treatment of an open
fracture model through a chitosan film impregnated with
ciprofloxacin showed a high rate of osteomyelitis com-
pared to the CT group submitted to antibiotic prophylaxis
with a significant difference. This result can be justified
by the small amount of antibiotic associated to a chitosan
film used in this study where the preparation had 10% of
the molecular weight of the membrane in antibiotic.
Further studies will be necessary to assess whether the
membrane of chitosan impregnated with ciprofloxacin in
higher concentrations of antibiotics or larger than that
used in this study will be effective in the prophylaxis of
osteomyelitis secondary to fractures. There are not stud-
ies in the literature using chitosan films impregnated
with ciprofloxacin for the prophylaxis of osteomyelitis sec-
ondary to open fractures.
As a strong point this study bring a new method of the
treatment for open fractures with local delivery of antibi-
otics through chitosan films resulting in higher local con-
centrations of drugs and lower systemic concentrations
and lower side effects. The weak points of this study is
that it is an experimental study, not tested in humans and
used just the concentration of 10% of antibiotics in chi-
tosan films that was not effective to avoid infection in this
model of open fracture.
5.1. Conclusion
The chitosan film pure or impregnated with
ciprofloxacin showed no efficacy in the prophylaxis of
osteomyelitis.
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